Literature DB >> 16677152

Measurement of parenchymal function and bile duct flow in primary sclerosing cholangitis using dynamic 99mTc-HIDA SPECT.

Eduard Jonas1, Erik Näslund, Jacob Freedman, Ragnar Befrits, Lennart Blomqvist, Anna-Karin Siösteen, Hans Jacobsson, Rolf Hultcrantz.   

Abstract

BACKGROUND AND AIM: Primary sclerosing cholangitis is a chronic cholestatic disease characterized by obliterative fibrosis of intrahepatic and/or extrahepatic bile ducts. The unpredictable clinical course of the disease can be relentless, leading to premature death in a large percentage of patients. Prognostic index formulas, the revised Mayo model being the most frequently used, have been developed to predict clinical course and prognosis. The aim of this study was to investigate the potential value of dynamic (99m)Tc-HIDA SPECT in patients with primary sclerosing cholangitis by correlating scintigraphic results with cholangiographic and biochemical findings and prognostic scoring systems used in clinical practice.
METHODS: In 18 patients with primary sclerosing cholangitis, segmental parenchymal and bile duct functions were measured using dynamic (99m)Tc-HIDA SPECT. Quantitative scintigraphic results were compared to cholangiographic findings, as graded by a biliary classification system, the Child-Pugh score and revised Mayo prognostic score, as well as the individual biochemical parameters included in the scoring systems.
RESULTS: In individual segments, scintigraphic quantitative parameters indicative of bile flow showed a statistically significant correlation with the state of the bile-flow path for the respective segments as assessed by the biliary classification system. The revised Mayo score correlated with the scintigraphic quantitative parameters indicative of parenchymal function and bile flow as calculated for the whole liver.
CONCLUSIONS: Dynamic (99m)Tc-HIDA SPECT, capable of assessing different aspects of liver function for the total liver, as well as for individual segments, has potential value in the management of patients with primary sclerosing cholangitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16677152     DOI: 10.1111/j.1440-1746.2005.04084.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  4 in total

1.  Spatially resolved assessment of hepatic function using 99mTc-IDA SPECT.

Authors:  Hesheng Wang; Yue Cao
Journal:  Med Phys       Date:  2013-09       Impact factor: 4.071

2.  Undetectable late hepatic sequelae after hypofractionated stereotactic radiotherapy for liver tumors.

Authors:  Peter Gunvén; Eduard Jonas; Henric Blomgren; Eva Rutkowska; Kristin Karlsson; Ingmar Lax; Seymour Levitt
Journal:  Med Oncol       Date:  2010-05-19       Impact factor: 3.064

3.  Predictive models for regional hepatic function based on 99mTc-IDA SPECT and local radiation dose for physiologic adaptive radiation therapy.

Authors:  Hesheng Wang; Mary Feng; Kirk A Frey; Randall K Ten Haken; Theodore S Lawrence; Yue Cao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-05-18       Impact factor: 7.038

4.  Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis.

Authors:  H Nilsson; L Blomqvist; L Douglas; A Nordell; I Janczewska; E Näslund; E Jonas
Journal:  Br J Radiol       Date:  2013-02-12       Impact factor: 3.039

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.